TheFly published on November 26, 2025, that Chardan kept its buy recommendation on CRISPR Therapeutics AG (NASDAQ:CRSP) while ...
2don MSN
CRISPR Therapeutics reports strong 90% response rate and lupus remission in landmark Zugo-Cel update
CRISPR Therapeutics (NASDAQ:CRSP) is one of the best emerging technology stocks to invest in. On December 22, CRISPR ...
In this article, we will discuss: 12 Best Genomics Stocks to Invest In. Companies that study DNA to improve people’s lives ...
16hon MSN
Contrarius Global Equity Fund’s Thoughts on CRISPR Therapeutics’ (CRSP) Gene Editing Therapy
Contrarius Investment Management, an investment management company, released its third-quarter investor letter for the ...
Zacks.com on MSN
CRISPR Therapeutics AG (CRSP) Stock Falls Amid Market Uptick: What Investors Need to Know
In the latest close session, CRISPR Therapeutics AG (CRSP) was down 2.5% at $56.46. The stock's performance was behind the S&P 500's daily gain of 0.46%. On the other hand, the Dow registered a gain ...
Cathie Wood aims to identify innovators and invest in them early in their stories. Wood has been regularly adding to her position in this stock, and it’s one of her top holdings. 10 stocks we like ...
These stocks have promising assets in their portfolios that could help make their valuations soar in the future.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback